16 Hrs
Source:
الاقتصادية
Likidia stock up 11% on patent deal
Lycadia announced the signing of a patent agreement with Union Therapeutics, ensuring continued supply of the medication YUTREPIA for the treatment of pulmonary arterial hypertension. Following this, the company's stock surged by 11%. This deal highlights the importance of intellectual property protection to ensure the distribution of vital medicines and the company's sustainable financial future.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)